Celldex Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Foreign
Celldex Therapeutics, Inc. (CLDX) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $4.49 million as of 2018-12-31, per its 10-K filed 2020-03-26.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2020-03-26
- 2018-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $4.49M.
- 2017-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $3.57M.
- 2016-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $1.12M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Foreign |
|---|---|
| 2018-12-31 | $4.49M 10-K · filed 2020-03-26 |
| 2017-12-31 | $3.57M 10-K · filed 2019-03-07 |
| 2016-12-31 | $1.12M 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |